Cord blood and tissue banking service provider Cordlife recorded its fourth consecutive quarter of revenue growth since listing in March last year.

The company reported a 192.7 per cent rise in net profit to $5.6 million for the three months ended Dec 31, compared to $1.9 million for same period the year before.

The company also reported a 23.9 per cent increase in revenue to $8.8 million, which was driven by an increase in the number of client deliveries.

It also recorded a one-time disposal gain of $2.7 million from the disposal of its 10 per cent interest in China Stem Cells (South) Company.